{"id":48913,"date":"2016-10-26T13:41:00","date_gmt":"2016-10-26T11:00:00","guid":{"rendered":"http:\/\/demo2016.hispanicprwire.com\/english-oxitec-opens-large-scale-mosquito-production-facility-in-brazil\/"},"modified":"2016-10-26T17:27:26","modified_gmt":"2016-10-26T21:27:26","slug":"oxitec-inaugura-planta-de-produccion-de-mosquitos-a-gran-escala-en-brasil","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/oxitec-inaugura-planta-de-produccion-de-mosquitos-a-gran-escala-en-brasil\/","title":{"rendered":"Oxitec Opens Large Scale Mosquito Production Facility in Brazil"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p>\n    <\/p>\n<\/p>\n<p><span class=\"xn-location\">OXFORD, England<\/span>, <span class=\"xn-chron\">Oct. 26, 2016<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;<a href=\"http:\/\/www.dna.com\/\" target=\"_blank\" rel=\"nofollow\">Intrexon Corporation<\/a> (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its wholly owned subsidiary <a href=\"http:\/\/www.oxitec.com\/\" target=\"_blank\" rel=\"nofollow\">Oxitec<\/a> has opened its new Friendly\u2122 Aedes mosquito production facility in Piracicaba, Brazil.\u00a0 The new 5,000 m\u00b2 facility has the capacity to produce 60 million Friendly\u2122 Aedes\u00a0per week which can help protect up to 3 million people by significantly reducing local populations of the dangerous <i>Aedes aegypti <\/i>mosquito.\u00a0 <\/p>\n<div id=\"prni_dvprnejpg17b3left\" style=\"TEXT-ALIGN: left; WIDTH: 100%\"><img decoding=\"async\" id=\"prnejpg17b3left\" title=\"Intrexon Corporation logo.\" border=\"0\" alt=\"Intrexon Corporation logo.\" align=\"middle\" src=\"http:\/\/photos.prnewswire.com\/prnvar\/20130919\/NY83283LOGO\"\/><\/div>\n<p>Lieutenant General (Ret.) <span class=\"xn-person\">Thomas P. Bostick<\/span>, Ph.D., P.E., Senior Vice President and Head of Intrexon&#8217;s Environment Sector stated, &#8220;The scalability of our biological solution has taken a meaningful step forward with the inauguration of this new world-class facility in Brazil.\u00a0 With the rising global incidence of harmful viral infections including Zika, dengue, chikungunya, yellow fever, and now Mayaro, driven primarily by the bite of the dangerous <i>Aedes aegypti<\/i>, it is essential we make Oxitec&#8217;s proven, unparalleled Friendly\u2122 Aedes vector control solution more available to the many countries this disease-spreading mosquito has invaded.\u00a0 We continue to engage and work with numerous government agencies and non-governmental organizations to achieve this mission.&#8221; <\/p>\n<p>Oxitec&#8217;s pioneering biological method involves the release of engineered, non-biting male mosquitoes that mate with wild females.\u00a0 The resulting offspring inherit a self-limiting gene preventing them from reaching adulthood and the males themselves die within days providing an eco-friendly solution that solely targets <i>Aedes aegypti<\/i> and does not persist in the environment. \u00a0Oxitec will utilize a portion of the new facility&#8217;s significant production capability to support its ongoing deployment program in Piracicaba&#8217;s downtown area and CECAP\/Eldorado district to suppress<i> Aedes aegypti<\/i>.\u00a0 <\/p>\n<p>In conjunction with independent collaborators, Oxitec has conducted five open field trials of its self-limiting mosquitoes in <span class=\"xn-location\">Brazil<\/span>, <span class=\"xn-location\">Panama<\/span> and the Cayman Islands.\u00a0 Each trial led to a greater than 90% reduction of the wild <i>Aedes aegypti<\/i> population, achieving these unparalleled suppression results within six months on average.\u00a0 More recently, Piracicaba&#8217;s Epidemiologic Surveillance service released data showing the incidence of dengue had decreased by 91% to just 12 cases in the CECAP\/Eldorado district where Friendly\u2122 Aedes mosquitoes were released, compared to a 52% reduction in the rest of the city during the same 12-month period.<\/p>\n<p>Notably the public support for the Friendly\u2122 Aedes project has been strong. A survey conducted by the CW7 Market Research Institute in mid-2016 showed that 98% of Piracicaba&#8217;s citizens support the use of innovative tools to fight dengue, Zika and chikungunya, and 88% support the use of Friendly\u2122 Aedes.<\/p>\n<p>&#8220;This Friendly\u2122 Aedes facility increases our current production capacity 30-fold in <span class=\"xn-location\">Brazil<\/span>&#8220;, says <span class=\"xn-person\">Glen Slade<\/span>, Oxitec&#8217;s VP and Director of Oxitec do Brasil. &#8220;This reaffirms our ability to produce Friendly\u2122 Aedes at scale, and we are ready to expand our production even further to help protect the people of <span class=\"xn-location\">Brazil<\/span> and beyond.&#8221;<\/p>\n<p><b>About Intrexon Corporation<br \/><\/b>Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA<sup>\u2122<\/sup> to create biologically-based products that improve the quality of life and the health of the planet.\u00a0 The Company&#8217;s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.\u00a0 We call our synthetic biology approach Better DNA<sup>\u00ae<\/sup>, and we invite you to discover more at <a href=\"http:\/\/www.dna.com\/\" target=\"_blank\" rel=\"nofollow\">www.dna.com<\/a> or follow us on Twitter at <a href=\"http:\/\/www.twitter.com\/intrexon\" target=\"_blank\" rel=\"nofollow\">@Intrexon<\/a>.<\/p>\n<p><b>Trademarks<br \/><\/b>Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and\/or its affiliates. Other names may be trademarks of their respective owners.<\/p>\n<p><b>Safe Harbor Statement<br \/><\/b>Some of the statements made in this press release are forward-looking statements.\u00a0 These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.\u00a0 Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.<\/p>\n<p><b>For more information contact:<br \/><\/b><b>Corporate Contact:<br \/><\/b><span class=\"xn-person\">Marie Rossi<\/span>, Ph.D. <br \/>Senior Manager, Technical Communications<br \/>Tel: +1 (301) 556-9850<br \/><a href=\"mailto:publicrelations@intrexon.com\" target=\"_blank\" rel=\"nofollow\">publicrelations@intrexon.com<\/a><\/p>\n<p><b>Investor Contact:<br \/><\/b><span class=\"xn-person\">Christopher Basta<\/span><br \/>Vice President, Investor Relations<br \/>Tel: +1 (561) 410-7052<br \/><a href=\"mailto:investors@intrexon.com\" target=\"_blank\" rel=\"nofollow\">investors@intrexon.com<\/a><\/p>\n<p><b>Oxitec Contact:<br \/><\/b><span class=\"xn-person\">Matthew Warren<\/span><br \/>Press Officer<br \/>Tel: +44 (0) 1235 832 393<br \/><a href=\"mailto:info@oxitec.com\" target=\"_blank\" rel=\"nofollow\">info@oxitec.com<\/a><\/p>\n<p>Logo &#8211; <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20130919\/NY83283LOGO\" target=\"_blank\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20130919\/NY83283LOGO<\/a> <\/p>\n<\/p>\n<p><\/p>\n<\/div>\n<p> <\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p>\n    <\/p>\n<\/p>\n<p><span class=\"xn-location\">OXFORD, England<\/span>, <span class=\"xn-chron\">Oct. 26, 2016<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;<a href=\"http:\/\/www.dna.com\/\" target=\"_blank\" rel=\"nofollow\">Intrexon Corporation<\/a> (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its wholly owned subsidiary <a href=\"http:\/\/www.oxitec.com\/\" target=\"_blank\" rel=\"nofollow\">Oxitec<\/a> has opened its new Friendly\u2122 Aedes mosquito production&#8230;<\/p>\n","protected":false},"author":1,"featured_media":48914,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-48913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/48913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=48913"}],"version-history":[{"count":0,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/48913\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media\/48914"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=48913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=48913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=48913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}